These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17042328)

  • 1. Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamide.
    De Martino G; La Regina G; Ragno R; Coluccia A; Bergamini A; Ciaprini C; Sinistro A; Maga G; Crespan E; Artico M; Silvestri R
    Antivir Chem Chemother; 2006; 17(2):59-77. PubMed ID: 17042328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives.
    Ragno R; Artico M; De Martino G; La Regina G; Coluccia A; Di Pasquali A; Silvestri R
    J Med Chem; 2005 Jan; 48(1):213-23. PubMed ID: 15634015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolyl aryl sulfones (IASs): development of highly potent NNRTIs active against wt-HIV-1 and clinically relevant drug resistant mutants.
    Silvestri R; Artico M
    Curr Pharm Des; 2005; 11(29):3779-806. PubMed ID: 16305512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains.
    Nalli M; Armijos Rivera JI; Masci D; Coluccia A; Badia R; Riveira-Muñoz E; Brambilla A; Cinquina E; Turriziani O; Falasca F; Catalano M; Limatola C; Esté JA; Maga G; Silvestri R; Crespan E; La Regina G
    Eur J Med Chem; 2020 Dec; 208():112696. PubMed ID: 32883642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.
    Regina GL; Coluccia A; Piscitelli F; Bergamini A; Sinistro A; Cavazza A; Maga G; Samuele A; Zanoli S; Novellino E; Artico M; Silvestri R
    J Med Chem; 2007 Oct; 50(20):5034-8. PubMed ID: 17803291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Famiglini V; La Regina G; Coluccia A; Pelliccia S; Brancale A; Maga G; Crespan E; Badia R; Clotet B; Esté JA; Cirilli R; Novellino E; Silvestri R
    Eur J Med Chem; 2014 Jun; 80():101-11. PubMed ID: 24769348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus.
    Piscitelli F; Coluccia A; Brancale A; La Regina G; Sansone A; Giordano C; Balzarini J; Maga G; Zanoli S; Samuele A; Cirilli R; La Torre F; Lavecchia A; Novellino E; Silvestri R
    J Med Chem; 2009 Apr; 52(7):1922-34. PubMed ID: 19281225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Famiglini V; La Regina G; Coluccia A; Pelliccia S; Brancale A; Maga G; Crespan E; Badia R; Riveira-Muñoz E; Esté JA; Ferretti R; Cirilli R; Zamperini C; Botta M; Schols D; Limongelli V; Agostino B; Novellino E; Silvestri R
    J Med Chem; 2014 Dec; 57(23):9945-57. PubMed ID: 25418038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex.
    Samuele A; Kataropoulou A; Viola M; Zanoli S; La Regina G; Piscitelli F; Silvestri R; Maga G
    Antiviral Res; 2009 Jan; 81(1):47-55. PubMed ID: 18984007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolyl aryl sulphones as HIV-1 reverse transcriptase inhibitors: docking and 3D QSAR studies.
    Ragno R; Coluccia A; La Regina G; Silvestri R
    Expert Opin Drug Discov; 2007 Jan; 2(1):87-114. PubMed ID: 23496039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide.
    La Regina G; Coluccia A; Brancale A; Piscitelli F; Gatti V; Maga G; Samuele A; Pannecouque C; Schols D; Balzarini J; Novellino E; Silvestri R
    J Med Chem; 2011 Mar; 54(6):1587-98. PubMed ID: 21366296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in-silico approach aimed to clarify the role of Y181C and K103N HIV-1 reverse transcriptase mutations versus Indole Aryl Sulphones.
    Massarotti A; Coluccia A
    J Mol Graph Model; 2016 Jan; 63():49-56. PubMed ID: 26650686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitors.
    Xu S; Song S; Sun L; Gao P; Gao S; Ma Y; Kang D; Cheng Y; Zhang X; Cherukupalli S; De Clercq E; Pannecouque C; Liu X; Zhan P
    Bioorg Med Chem; 2022 Jan; 53():116531. PubMed ID: 34890994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors.
    La Regina G; Coluccia A; Brancale A; Piscitelli F; Famiglini V; Cosconati S; Maga G; Samuele A; Gonzalez E; Clotet B; Schols D; Esté JA; Novellino E; Silvestri R
    J Med Chem; 2012 Jul; 55(14):6634-8. PubMed ID: 22712652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations.
    Silvestri R; Artico M; De Martino G; La Regina G; Loddo R; La Colla M; Mura M; La Colla P
    J Med Chem; 2004 Jul; 47(15):3892-6. PubMed ID: 15239667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 5H-indolo [3,2-b][1,5]benzothiazepine derivatives, designed as conformationally constrained analogues of the human immunodeficiency virus type 1 reverse transcriptase inhibitor L-737,126.
    Silvestri R; Artico M; Bruno B; Massa S; Novellino E; Greco G; Marongiu ME; Pani A; De Montis A; La Colla P
    Antivir Chem Chemother; 1998 Mar; 9(2):139-48. PubMed ID: 9875385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches.
    Huang B; Li C; Chen W; Liu T; Yu M; Fu L; Sun Y; Liu H; De Clercq E; Pannecouque C; Balzarini J; Zhan P; Liu X
    Eur J Med Chem; 2015 Mar; 92():754-65. PubMed ID: 25626145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.
    Ragno R; Coluccia A; La Regina G; De Martino G; Piscitelli F; Lavecchia A; Novellino E; Bergamini A; Ciaprini C; Sinistro A; Maga G; Crespan E; Artico M; Silvestri R
    J Med Chem; 2006 Jun; 49(11):3172-84. PubMed ID: 16722636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
    Famiglini V; La Regina G; Coluccia A; Masci D; Brancale A; Badia R; Riveira-Muñoz E; Esté JA; Crespan E; Brambilla A; Maga G; Catalano M; Limatola C; Formica FR; Cirilli R; Novellino E; Silvestri R
    J Med Chem; 2017 Aug; 60(15):6528-6547. PubMed ID: 28628334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies.
    Silvestri R; De Martino G; La Regina G; Artico M; Massa S; Vargiu L; Mura M; Loi AG; Marceddu T; La Colla P
    J Med Chem; 2003 Jun; 46(12):2482-93. PubMed ID: 12773052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.